Niessner et al. reported that the release of paracrine signaling factors produced by carcinoma-associated fibroblasts stimulate survival pathways such as the Akt-pathway and reduce cytotoxic effects of chemotherapies [22]. The gene discussed is AKT1; the disease is carcinoma.